Stockreport

Roche presents novel therapeutic and diagnostic advancements in Alzheimer's at AD/PD 2025 [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF Data on the Elecsys® pTau181 plasma test demonstrate potential to accurately rule out amyloid pathology, one of the hallmarks of Alzheimer's disease Roche will initia [Read more]